Erratum for

• An international comparison of anti-SARS-COV-2 assays used for seroprevalence surveys from blood component providers.

  Lewin A, Drews SJ, Lieshout-Krikke R, Erikstrup C, Saeed S, Fady H, Uzicanin S, Custer B, O'Brien SF; Surveillance, Risk Assessment, Policy, the Virology Sub-groups of the ISBT Transfusion Transmitted Infectious Diseases Working Party. Lewin A, et al. Vox Sang. 2021 Oct;116(9):946-954. doi: 10.1111/vox.13100. Epub 2021 Apr 29. Vox Sang. 2021. PMID: 33914918 Free PMC article.
• DUAL I China: Improved glycemic control with IDegLira versus its individual components in a randomized trial with Chinese participants with type 2 diabetes uncontrolled on oral antidiabetic drugs.

  Wang W, Agner BFR, Luo B, Liu L, Liu M, Peng Y, Qu S, Stachlewska KA, Wang G, Yuan G, Zhang Q, Ning G. Wang W, et al. J Diabetes. 2022 Jun;14(6):401-413. doi: 10.1111/1753-0407.13286. J Diabetes. 2022. PMID: 35762390 Free PMC article. Clinical Trial.